ImageneBio, Inc. Restructuring Charges
ImageneBio, Inc. (IMA) reported Restructuring Charges of $309.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-07-24
- ImageneBio, Inc. restructuring charges for the quarter ending 2025-06-30 was $309.00K, a 54.76% decline year-over-year.
- ImageneBio, Inc. restructuring charges for the quarter ending 2025-03-31 was $1.44M, a 44.42% decline year-over-year.
- ImageneBio, Inc. restructuring charges for the quarter ending 2024-12-31 was $342.00K.
- ImageneBio, Inc. restructuring charges for the quarter ending 2024-09-30 was $812.00K.
- ImageneBio, Inc. restructuring charges for fiscal 2024 was $4.42M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2025-06-30 | $309.00K 10-Q · filed 2025-07-24 | $1.74M 10-Q · filed 2025-07-24 | $2.09M derived: sum of 3 quarters · filed 2025-07-24 | $2.90M derived: sum of 4 quarters · filed 2025-07-24 |
| 2025-03-31 | $1.44M 10-Q · filed 2025-05-08 | $1.78M derived: sum of 2 quarters · filed 2025-05-08 | $2.59M derived: sum of 3 quarters · filed 2025-05-08 | $3.27M derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.15M derived: sum of 2 quarters · filed 2025-03-06 | $1.84M derived: sum of 3 quarters · filed 2025-07-24 | $4.42M 10-K · filed 2025-03-06 |
| 2024-09-30 | $812.00K 10-Q · filed 2024-11-07 | $1.50M derived: sum of 2 quarters · filed 2025-07-24 | $4.08M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $683.00K 10-Q · filed 2025-07-24 | $3.27M 10-Q · filed 2025-07-24 | ||
| 2024-03-31 | $2.58M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |